Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Chotchai Charoenngam | M | 61 |
Asian Institute of Technology
| 26 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul J. Schechter | M | 84 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
Eliot Lurier | M | 66 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 years |
Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
David Holtz | M | 58 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
Shao Hua Dai | M | 41 |
University of Limerick
| 1 years |
Drajad Widiyanto | M | 60 |
Asian Institute of Technology
| 1 years |
Paul Adams | M | - |
University of Limerick
| 1 years |
John Shinnick | M | - |
University of Limerick
| 4 years |
John Mescall | M | 43 |
University of Limerick
| 4 years |
Setiawan Wangsaatmaja | M | 61 |
Asian Institute of Technology
| 2 years |
Ross Nicholas | M | - |
University of Limerick
| 4 years |
Kate Madden | F | - |
University of Limerick
| 6 years |
Elaine Collins | F | - |
University of Limerick
| 4 years |
Allan Mulrooney | M | - |
University of Limerick
| 4 years |
Audrey Crummy | F | - |
University of Limerick
| 4 years |
Shane Clifford | M | - |
University of Limerick
| 4 years |
Alan Cuddihy | M | - |
University of Limerick
| 4 years |
Aisling Meehan | F | - |
University of Limerick
| 4 years |
Paul Kelly | M | - |
University of Limerick
| 4 years |
Thongphet Chanthanivong | M | 62 |
Asian Institute of Technology
| 2 years |
Keith James McKnight | M | - |
University of Limerick
| 4 years |
Thang Minh Nguyen | M | 56 |
Asian Institute of Technology
| 1 years |
Dwayne McNicholas | M | - |
University of Limerick
| 4 years |
G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 years |
Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 years |
Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 years |
David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
Scott H. Gillis | M | 71 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 8 years |
Katherine J. Turner | M | 70 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Paul Gleeson | M | - |
University of Limerick
| 4 years |
Irakli Gilauri | M | 48 |
University of Limerick
| 4 years |
Antoin Russell | M | - |
University of Limerick
| 2 years |
Alan Dunne | M | - |
University of Limerick
| 2 years |
Karl-Heinz Rinne | M | - |
University of Limerick
| 5 years |
Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Martin Mellody | M | - |
University of Limerick
| 1 years |
David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
Steve Mason | M | - |
University of Limerick
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Ireland | 22 | 51.16% |
United States | 16 | 37.21% |
Thailand | 5 | 11.63% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roger G. H. Downer
- Personal Network